Skip to main content
. 2020 Jul 1;35(Suppl 2):97. doi: 10.11604/pamj.supp.2020.35.2.24612

Figure 4.

Figure 4

Testing coverage over time, with a horizontal line marking the 69% upper estimate symptomatic ratio of COVID-19